CMS Releases Proposed 2014 Star Ratings Methodology
Client Alert | less than 1 min read | 12.12.12
November 30, CMS released its proposed methodology for 2014 Star Ratings for Medicare Advantage and Prescription Drug Plans, also referred to as Plan Ratings. It also includes some potential changes for the 2015 Star Ratings and beyond to give plans advance notice. Comments are due January 3, 2014.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
